Samsung Biologics Market Cap

Samsung Biologics has a market cap or net worth of 72.81 trillion as of April 16, 2025. Its market cap has increased by 19.09% in one year.

Market Cap

72.81T

Enterprise Value

72.97T

Revenue

4.55T

Ranking

n/a

PE Ratio

67.21

Stock Price

1,023,000.00

Market Cap Chart

Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 72.81T, an increase of 664.20%. That is a compound annual growth rate of 27.27%.

Market Cap History

Date	Market Cap	% Change
Apr 15, 2025	73.59T	8.96%
Dec 30, 2024	67.54T	24.87%
Dec 28, 2023	54.09T	-7.43%
Dec 29, 2022	58.43T	-2.20%
Dec 30, 2021	59.75T	9.32%
Dec 30, 2020	54.65T	90.76%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Celltrion	34.41T
ALTEOGEN	20.25T
Yuhan	8,492.40B
SK Biopharmaceuticals	8,066.26B
HLB Co., Ltd.	7,094.07B
LigaChem Biosciences	3,972.88B
PharmaResearch	3,807.81B
Peptron	3,746.21B

Market Cap Rankings